News
Novo Nordisk slashes price of Ozempic
Digest more
No one stays on top forever. It’s a lesson that Ozempic maker Novo Nordisk may be painfully learning about. The Danish ...
A rumor that pharmaceutical companies behind popular weight-loss and diabetes medications like Ozempic faced lawsuits ...
On Friday, Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) had approved Wegovy for the treatment of ...
In the past year or couple of years, you’ve likely heard a lot about Ozempic, most likely in the context of weight loss. Not ...
The pharma giant has almost doubled the size of its workforce over the last five years but is now looking to tighten cost ...
Canada has approved Novo Nordisk's diabetes drug, Ozempic, to cut chronic kidney disease progression and reduce the risk of ...
With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030.
A steep decline in Ozempic maker Novo Nordisk’s share price has sent consumer confidence in Denmark to a three-month ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback